Scott M. Giacobello

CIK: 0001754154

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)4 (30.8%)

Position reduction

Option Exercises (M)3 (23.1%)

Derivative conversions

Awards (A)6 (46.2%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

WHWK

Whitehawk Therapeutics, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (13 total)

WHWK
Whitehawk Therapeutics, Inc.
Sep 15, 2026
Award(A)
Stock Option (right to buy)
Direct
118.5K shares-
WHWK
Whitehawk Therapeutics, Inc.
Sep 15, 2026
Award(A)
Restricted Stock Units
Direct
118.5K shares-
WHWK
Whitehawk Therapeutics, Inc.
May 14, 2026
Award(A)
Direct
38.3K shares at avg. $3.92$150K
WHWK
Whitehawk Therapeutics, Inc.
Apr 16, 2026
Sale(S)
Direct
141.6K shares at avg. $4.13$585K
WHWK
Whitehawk Therapeutics, Inc.
Apr 15, 2026
Sale(S)
Direct
77K shares at avg. $3.86$297K
WHWK
Whitehawk Therapeutics, Inc.
Apr 1, 2026
Award(A)
Stock Option (right to buy)
Direct
300.7K shares-
WHWK
Whitehawk Therapeutics, Inc.
Apr 1, 2026
Exercise(M)
Direct
473.9K shares-
WHWK
Whitehawk Therapeutics, Inc.
Mar 2, 2026
Sale(S)
Direct
2.6K shares at avg. $3.31$9K
WHWK
Whitehawk Therapeutics, Inc.
Mar 1, 2026
Exercise(M)
Direct
6.8K shares-
WHWK
Whitehawk Therapeutics, Inc.
Apr 1, 2025
Award(A)
Restricted Stock Units
Direct
473.9K shares-
WHWK
Whitehawk Therapeutics, Inc.
Apr 1, 2025
Award(A)
Stock Option (right to buy)
Direct
473.9K shares-
AADI
Aadi Bioscience, Inc.
Mar 3, 2025
Sale(S)
Direct
2.8K shares at avg. $2.35$7K
AADI
Aadi Bioscience, Inc.
Mar 1, 2025
Exercise(M)
Direct
6.8K shares-

		Type	Shares	Price		Ownership
Sep 15, 2026	WHWK Whitehawk Therapeutics, Inc.	Award(A) Stock Option (right to buy)	118,476	-	-	Direct
Sep 15, 2026	WHWK Whitehawk Therapeutics, Inc.	Award(A) Restricted Stock Units	118,476	-	-	Direct
May 14, 2026	WHWK Whitehawk Therapeutics, Inc.	Award(A)	38,265	$3.92	$149,999	Direct
Apr 16, 2026	WHWK Whitehawk Therapeutics, Inc.	Sale(S)	141,600	$4.13	$584,808	Direct
Apr 15, 2026	WHWK Whitehawk Therapeutics, Inc.	Sale(S)	77,000	$3.86	$297,220	Direct
Apr 1, 2026	WHWK Whitehawk Therapeutics, Inc.	Award(A) Stock Option (right to buy)	300,677	-	-	Direct
Apr 1, 2026	WHWK Whitehawk Therapeutics, Inc.	Exercise(M)	473,902	-	$0	Direct
Mar 2, 2026	WHWK Whitehawk Therapeutics, Inc.	Sale(S)	2,594	$3.31	$8,585	Direct
Mar 1, 2026	WHWK Whitehawk Therapeutics, Inc.	Exercise(M)	6,750	-	$0	Direct
Apr 1, 2025	WHWK Whitehawk Therapeutics, Inc.	Award(A) Restricted Stock Units	473,902	-	-	Direct
Apr 1, 2025	WHWK Whitehawk Therapeutics, Inc.	Award(A) Stock Option (right to buy)	473,902	-	-	Direct
Mar 3, 2025	AADI Aadi Bioscience, Inc.	Sale(S)	2,806	$2.35	$6,594	Direct
Mar 1, 2025	AADI Aadi Bioscience, Inc.	Exercise(M)	6,750	-	-	Direct

1-13 of 13 transactions

About Giacobello Scott M.

Giacobello Scott M. (SEC CIK 0001754154) files insider reports with the SEC as CHIEF FINANCIAL OFFICER of Whitehawk Therapeutics, Inc. (WHWK).

Signal8 holds 8 ownership filings by Giacobello Scott M., all Form 4s, filed between Mar 3, 2025 and Sep 18, 2026. Those filings report 13 transactions, from Mar 1, 2025 to Sep 15, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Giacobello Scott M.'s filings is in MORRISTOWN, NJ.

Recent filings by Giacobello Scott M.

Sep 15, 2026: Grants or awards of WHWK derivative securities (2 lines, Form 4, code A).
May 14, 2026: Grant or award of WHWK shares (Form 4, code A).
Apr 16, 2026: Open-market sale of WHWK shares (Form 4, code S).
Apr 15, 2026: Open-market sale of WHWK shares (Form 4, code S).
Apr 1, 2026: Grant or award of WHWK derivative securities (Form 4, code A).

Other insiders filing for Whitehawk Therapeutics, Inc. (WHWK)

BALL BRYAN
Dornan David, Chief Scientific Officer
Lennon David James, CHIEF EXECUTIVE OFFICER
Dugan Margaret, Chief Medical Officer
Iyengar Vijay K, Director
Dalal Anupam, Director

How to read Form 4 transaction codes